The European Medicines Agency made its determination after examining a small number of clot cases in people vaccinated in the U.S. It said these problems should be considered “very rare side effects of the vaccine.”

Concerns about new coronavirus variants more easily infecting people under age 16, who are not yet eligible for COVID-19 vaccines, have increased as case counts have gone up.

Travel is also discouraged for the remaining 20%, though not as emphatically. It says people with plans to visit those countries should reconsider before proceeding.

The Centers for Disease Control and Prevention says frequent cleanings might not have much of an impact on viral transmission.

The Johnson & Johnson COVID-19 Vaccine remains on a distribution pause after a decision from the CDC and Food and Drug Administration.

Just over 40% of Wisconsinites have received at least one COVID-19 shot, while nearly 28% have completed their vaccination series.

The Johnson & Johnson vaccine is in limbo in the U.S. after federal health advisers said last week they needed more evidence to decide if a handful of unusual blood clots were linked to the shot.

The United States will likely move to resume Johnson & Johnson’s COVID-19 vaccine this coming week, possibly with restrictions or broader warnings after reports of some very rare blood clot cases, the government’s top infectious diseases expert said Sunday.

The suspect faces multiple assault charges for allegedly hitting the officer with a rescue hammer and a store employee with a piece of lumber.

A Connecticut middle school teacher who raised $41,000 to help hundreds of his struggling neighbors during the COVID-19 pandemic is facing a potential tax bill of over $16,000.